3 more blood pres­sure drugs re­called over can­cer con­cern

Milwaukee Journal Sentinel - - Milwaukee Wisconsin -

A generic drug com­pany has re­called three com­monly pre­scribed blood pres­sure med­i­ca­tions over con­cerns they could in­clude small amounts of a can­cer-caus­ing im­pu­rity.

The re­called drugs all in­clude the blood-pres­sure med­i­ca­tion val­sar­tan, the sub­ject of a se­ries of re­calls by sev­eral drug com­pa­nies since July.

My­lan Phar­ma­ceu­ti­cals re­called 104 lots of three med­i­ca­tions: val­sar­tan tablets, com­bi­na­tion tablets with the drugs val­sar­tan and am­lodip­ine, and com­bi­na­tion tablets with val­sar­tan and hy­drochloroth­iazide.

Tests re­vealed that val­sar­tan con­tained trace amounts of a pos­si­ble hu­man car­cino­gen, the com­pany said.

My­lan said pa­tients should con­sult their doc­tor or phar­ma­cist be­fore stop­ping their cur­rent med­i­ca­tion.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.